Home LiteratureArticle Details
PMID: 6418552 Published · ppublish English Journal Article

Regulation of muscarinic agonist binding by cations and guanine nucleotides.

European journal of pharmacology ·Vol. 94 ·No. 1-2 ·1983-10-14 ·Pages 59-72

Hulme EC, Berrie CP, Birdsall NJ, Jameson M, Stockton JM

Abstract

EDTA treatment of membrane preparations from rat brain and myocardium reduced the relative proportion of superhigh and high affinity binding sites for muscarinic agonists by up to 60%. This effect was partially or completely reversed by millimolar concentrations of Mg2+ or Mn2+. A number of multivalent metal cations gave qualitatively similar effects, yielding stimulation of agonist binding at low concentrations but inhibition at higher concentrations. The divalent cation-linked subpopulation of muscarinic agonist binding sites identified in this study appears to be the primary target for guanine nucleotide inhibition.

MeSH Terms
Animals Cations/physiology Edetic Acid/pharmacology Guanine Nucleotides/physiology Guanylyl Imidodiphosphate/pharmacology In Vitro Techniques Kinetics Magnesium/pharmacology Male Manganese/pharmacology Membranes/metabolism Oxotremorine/metabolism Rats Receptors, Muscarinic/metabolism Sodium Chloride/pharmacology
Chemicals
Cations Guanine Nucleotides Receptors, Muscarinic Guanylyl Imidodiphosphate Manganese Sodium Chloride Oxotremorine Edetic Acid Magnesium
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Hulme E C
Berrie C P
Birdsall N J
Jameson M
Stockton J M
Article Info
Journal
European journal of pharmacology
Abbr.
Eur J Pharmacol
ISSN
0014-2999
Published
1983-10-14
Pages
59-72
Language
English
Region
Netherlands
NLM ID
1254354
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com